PRESTIGE® 3 + WNV
For the vaccination of healthy horses 6 months or older against Eastern and Western encephalomyelitis viruses, tetanus and West Nile Virus
LEARN MOREGilvetmab
Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFERTAGYL®
Is indicated for the treatment of ovarian follicular cysts in dairy cattle. Ovarian cysts are non-…
LEARN MOREPRESTIGE® TETANUS (Tetanus)
Shown to be effective for the vaccination of healthy horses, cattle, swine and sheep 6 months of age or older against tetanus.
LEARN MOREPRESTIGE® PRODIGY® (EHV-1, reproductive/respiratory)
Shown to be effective for the vaccination of healthy horses 6 months of age or older against abortion and respiratory disease caused by EHV-1
LEARN MOREPRESTIGE® EQUIRAB®
Shown to be effective for the vaccination of healthy horses 4 months of age or older against rabies virus.
LEARN MOREPRESTIGE® 5 + WNV
For the vaccination of healthy horses 6 months or older against EEE and WEE viruses, EIV, EHV-1, EHV-4, tetanus and West Nile Virus.
LEARN MOREPRESTIGE® 5
For the vaccination of healthy horses 6 months or older against EEE and WEE viruses, EIV, EHV-1, EHV-4, and tetanus.
LEARN MOREPRESTIGE® 4
For the vaccination of healthy horses 6 months or older against Eastern and Western encephalomyelitis, equine influenza virus and tetanus.
LEARN MOREPRESTIGE® 3
For the vaccination of healthy horses 6 months or older against Eastern and Western encephalomyelitis viruses and tetanus.
LEARN MOREPRESTIGE® 2
For the vaccination of healthy horses 6 months or older against equine influenza, equine herpesvirus type 1 and equine herpesvirus type 4.
LEARN MOREPRESTIGE® WNV
For the vaccination of healthy horses 6 months or older against West Nile Virus. Shown effective against encephalitis and viremia caused by West Nile Virus
LEARN MORE
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global